Jesper D. Gunst
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
From passive protection to lasting immunity: the potential vaccinal effect of antiviral monoclonal antibodies.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 25, 2026
Functional T Cell Responses Are Associated With Prolonged HIV Control After Treatment Interruption.
Journal: The Journal of infectious diseases
Published: March 02, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ART.
Journal: Nature communications
Published: October 21, 2025
The impact of magnitude and duration of plasma viremia during analytical treatment interruptions on CD4+ T cell recovery after ART resumption.
Journal: Journal of virus eradication
Published: June 10, 2025
CD8+ T cell stemness precedes post-intervention control of HIV viraemia.
Journal: Nature
Published: April 20, 2025
Factors Influencing Virologic Control During Analytical Treatment Interruptions in HIV Cure Trials-a Pooled Analysis of Individual-Level Data.
Journal: The Journal of infectious diseases
Published: November 27, 2024
Last Updated: 09/26/2026